95.03
price down icon0.05%   -0.01
 
loading
Revvity Inc stock is traded at $95.03, with a volume of 105.24K. It is down -0.05% in the last 24 hours and down -2.89% over the past month. Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$95.04
Open:
$94.84
24h Volume:
105.24K
Relative Volume:
0.08
Market Cap:
$11.21B
Revenue:
$2.77B
Net Income/Loss:
$286.61M
P/E Ratio:
40.44
EPS:
2.35
Net Cash Flow:
$524.11M
1W Performance:
-1.18%
1M Performance:
-2.89%
6M Performance:
-23.09%
1Y Performance:
-24.36%
1-Day Range:
Value
$94.06
$95.30
1-Week Range:
Value
$92.62
$104.41
52-Week Range:
Value
$87.70
$129.50

Revvity Inc Stock (RVTY) Company Profile

Name
Name
Revvity Inc
Name
Phone
781-663-6900
Name
Address
77 4TH AVENUE, WALTHAM
Name
Employee
11,000
Name
Twitter
Name
Next Earnings Date
2025-07-28
Name
Latest SEC Filings
Name
RVTY's Discussions on Twitter

Compare RVTY with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
RVTY
Revvity Inc
95.10 12.22B 2.77B 286.61M 524.11M 2.35
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
482.60 180.56B 43.21B 6.58B 6.17B 17.29
Diagnostics & Research icon
DHR
Danaher Corp
203.63 147.13B 24.01B 3.41B 4.86B 4.70
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
569.24 45.45B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
119.32 34.14B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
196.19 33.86B 15.50B 1.33B 2.16B 7.34

Revvity Inc Stock (RVTY) Upgrades & Downgrades

Date Action Analyst Rating Change
May-01-25 Upgrade UBS Neutral → Buy
Jan-10-25 Downgrade Bernstein Outperform → Mkt Perform
Dec-13-24 Upgrade BofA Securities Neutral → Buy
Oct-15-24 Upgrade Barclays Equal Weight → Overweight
Aug-28-24 Initiated Wells Fargo Equal Weight
Jul-08-24 Initiated Leerink Partners Outperform
Jun-03-24 Resumed Jefferies Hold
Jan-16-24 Downgrade UBS Buy → Neutral
Jan-04-24 Upgrade Evercore ISI In-line → Outperform
Dec-19-23 Initiated Wells Fargo Equal Weight
Dec-13-23 Initiated Wolfe Research Peer Perform
Sep-28-23 Initiated Bernstein Outperform
Jul-19-23 Initiated Raymond James Outperform
May-23-23 Resumed Goldman Buy
View All

Revvity Inc Stock (RVTY) Latest News

pulisher
08:21 AM

Revvity, Inc. (NYSE:RVTY) Q2 2025 Earnings Call Transcript - Insider Monkey

08:21 AM
pulisher
08:08 AM

Revvity stock price target lowered to $115 by Bernstein on China headwinds - Investing.com Australia

08:08 AM
pulisher
07:13 AM

Revvity: Not A Healthy Diagnosis For This Life Science Business (NYSE:RVTY) - Seeking Alpha

07:13 AM
pulisher
03:02 AM

Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ... - Yahoo Finance

03:02 AM
pulisher
02:41 AM

Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ... By GuruFocus - Investing.com Canada

02:41 AM
pulisher
Jul 28, 2025

Revvity’s Resilience: Strong Performance and Growth Opportunities Amidst Challenges - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity, Inc. Earnings Call: Mixed Sentiment and Strategic Moves - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Stock Sinks on Lowered China Immunodiagnostics Outlook - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

U.S. Markets Closed Mixed Monday As Super Micro Computer Led, Revvity Lagged - Barron's

Jul 28, 2025
pulisher
Jul 28, 2025

Why Revvity (RVTY) Stock Is Falling Today - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Q2: Headwinds From China And Customers, Buy On Weakness (NYSE:RVTY) - Seeking Alpha

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity targets 2%-4% organic growth for 2025 as China diagnostics faces new policy headwinds - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity stock price target lowered to $100 at Jefferies on China headwinds - Investing.com Australia

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ - Stocktwits

Jul 28, 2025
pulisher
Jul 28, 2025

Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today By Stocktwits - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Stock Tumbles After Earnings. What’s Dragging On the Shares. - Barron's

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Stock Dips on Lowered FY25 EPS Guidance Despite Revenue Optimism - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity: Q2 Earnings Snapshot - CTPost

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity sinks after slashing its full-year profit outlook - Sherwood News

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity (RVTY) Faces China-Driven Headwinds: Is the Selloff a Buying Opportunity or a Warning Signal? - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity (RVTY) Shares Tumble Amid Market Activity - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity's Q2 2025 Earnings Call: Navigating Contradictions in Revenue Growth, Market Dynamics, and Regulatory Impacts - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Top Stock Movers Now: Nike, Cheniere Energy, Revvity, and More - Investopedia

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity's Earnings Beat vs. Stock Sell-Off: A Contrarian Opportunity in Diagnostics? - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Slashes Outlook As China Policy Deals Diagnostics Blow - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Plunges 9.8% as China Reimbursement Shifts Trigger Sell-Off—Is This a Buying Opportunity or a Warning Sign? - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View - Barchart.com

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity trims 2025 profit forecast as China policy changes hit diagnostics demand - Reuters

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity trims 2025 profit forecast on soft demand for diagnostics in China - whbl.com

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity (RVTY) Stock Experiences Significant Decline - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Stock Tumbles After Earnings. What's Dragging on the Shares - 富途牛牛

Jul 28, 2025
pulisher
Jul 28, 2025

Earnings Summary: Revvity (RVTY) reports higher Q2 2025 revenues - AlphaStreet

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - sg.finance.yahoo.com

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Q2 Revenue Up 4 Percent - AOL.com

Jul 28, 2025
pulisher
Jul 28, 2025

Earnings call transcript: Revvity Q2 2025 beats earnings expectations By Investing.com - Investing.com India

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity 2025 Q2 Earnings Beats Expectations as Net Income Falls 2.6% - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Surpasses Q2 Forecasts with Solid Revenue Growth Across Divisions - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Lowers 2025 Outlook As China Sales Falter - Finimize

Jul 28, 2025
pulisher
Jul 28, 2025

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session - 富途牛牛

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Trims 2025 Profit Forecast as China Policy Changes Hit Diagnostics Demand - US News Money

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Stock Tumbles After Earnings. What’s Dragging on the Shares. - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity, Inc. Reports Strong Q2 Earnings, Surpassing Market ExpectationsNews and Statistics - IndexBox

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Q2 Revenue Up 4 Percent - The Motley Fool

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Inc (RVTY) Q2 2025 Earnings: Revenue Surpasses Estimates at $720M, GAAP EPS Falls Short at $0.46 - GuruFocus

Jul 28, 2025
pulisher
Jul 28, 2025

S&P 500 Futures Rise in Premarket Trading; Revvity, Albemarle Lag - Barron's

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity (RVTY) Reports Strong Second Quarter 2025 Results, Outperforms Expectations - Tokenist

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Announces Financial Results for Q2 2025 - TradingView

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Raises 2025 Revenue Guidance - Nasdaq

Jul 28, 2025
pulisher
Jul 28, 2025

Revvity Q2 2025 slides: Revenue growth continues amid margin pressure - Investing.com Australia

Jul 28, 2025

Revvity Inc Stock (RVTY) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research WAT
$301.83
price down icon 0.22%
$135.79
price down icon 1.33%
diagnostics_research DGX
$168.15
price up icon 0.43%
diagnostics_research LH
$261.20
price down icon 0.18%
diagnostics_research MTD
$1,256.31
price down icon 0.09%
diagnostics_research IQV
$196.60
price down icon 0.38%
Cap:     |  Volume (24h):